Posts

Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses – key facts and context

on

Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date

on

Abivax stock falls on cancer cases despite strong ulcerative colitis phase 3 data

on

FDA's Move to Update GSK's Leucovorin for Autism Raises Questions on Dose, Supply, and Data

on

FDA Lifts Hold on Rocket Pharmaceuticals' Pivotal Gene Therapy Study at Lower Dose

on

Amgen Adjusts Phase 3 Dosing for MariTide After Midstage Side Effects Concerns

on

Lilly Makes All Zepbound Doses Available via Direct Pay Program

on

Lexicon stumbles on second batch of mixed results for pain drug

on

Lilly lowers price of Zepbound vials, launches new doses

on

Eli Lilly makes Zepbound vials cheaper for self-paying patients

on